Tralokinumab Improves Clinically Relevant Outcome Measures: A Post Hoc Analysis of ECZTRA 3, A Randomized Clinical Trial in Patients with Moderate-To-Severe Atopic Dermatitis
Keyword(s):
Post Hoc
◽
Abstract not available.
2019 ◽
Vol 21
(1)
◽
pp. 119-131
◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 198
(1)
◽
pp. 58-66
◽
2017 ◽
Vol 76
(6)
◽
pp. AB416
◽
Keyword(s):
2020 ◽
Vol 56
(10)
◽
pp. 681-683
◽
Keyword(s):